Loading organizations...

Contessa is a technology company.
Contessa Health provides comprehensive healthcare services directly to patients in their homes, partnering with healthcare systems and plans. The company offers a suite of services, including Home Recovery Care for seriously ill patients who would otherwise require inpatient hospitalization, Rehabilitation Care at Home, and Palliative Care at Home. This model aims to deliver high-quality, cost-effective care outside traditional hospital settings, focusing on the patient's healing environment.
The company was founded in 2015 by Travis Messina, whose family history inspired its inception. Messina’s family roots in Contessa Entellina, Italy, and their experiences as immigrants needing accessible healthcare, led to the formation of the Contessa Entellina Society of New Orleans in 1886, which aided new arrivals in receiving care at home. This legacy of bringing healthcare home directly informs Contessa Health’s current mission and service delivery model.
Contessa Health serves healthcare systems, health plans, and their patients by making the healing experience more enjoyable for all involved. Its vision is to foster a growing continuum of services that enable individuals to recover and manage their health from the comfort and familiarity of their homes. The company is committed to expanding its innovative approach to in-home care delivery across the United States.
Contessa has raised $59.5M across 4 funding rounds.
Contessa has raised $59.5M in total across 4 funding rounds.
Contessa has raised $59.5M in total across 4 funding rounds.
Contessa's investors include Health Velocity Capital, BlueCross BlueShield Venture Partners, Marshfield Clinic Health System, Martin Ventures, Nashville Capital Network, Sandbox Industries, Anna Haghgooie, Charles N. Martin.
Contessa Health is a Nashville-based healthcare technology company pioneering Home Recovery Care, a risk-based model delivering hospital-level and skilled nursing facility (SNF) care in patients' homes as an alternative to inpatient stays.[1][2][4] It serves health systems, health plans, physicians, and patients by solving high healthcare costs, administrative burdens, and suboptimal outcomes through its proprietary CareConvergence™ platform, which powers cost-saving analytics, patient tracking, revenue cycle optimization, and secure data integration.[1][3][7] Acquired by Amedisys in 2021 for $250 million, Contessa now operates as a wholly owned division, partnering with 11 health systems and multiple plans across nine states to provide recovery, rehabilitation, and palliative care at home, demonstrating strong growth via expansions like CommonSpirit Health and Medicare dementia care pilots.[1][4][5]
Founded in 2015 in Nashville, Tennessee, Contessa emerged to address the need for affordable, high-quality alternatives to traditional hospital inpatient care and SNF admissions.[1][2][4] The company quickly gained traction as the pioneer of Home Recovery Care, leveraging its proprietary informatics platform CareConvergence™ to coordinate seamless at-home delivery.[1][3] Key milestones include partnerships with major health systems like CommonSpirit Health for launches in Phoenix, selection by CMS for Medicare dementia care testing, and the pivotal 2021 acquisition by Amedisys, which included commitments for further investment in its technology and expansion.[1][4][5]
Contessa rides the shift to value-based, home-centered care, fueled by rising healthcare costs, patient preference for comfort, and post-COVID acceleration of telehealth and remote monitoring.[1][4][7] Timing aligns with payer pressures for risk arrangements and CMS innovations like dementia care models, positioning it amid market forces favoring lower-cost alternatives to inpatient settings—where homes replicate full hospital/SNF elements safely.[1][5] It influences the ecosystem by enabling health systems to personalize acute/chronic care, partnering with giants like Amedisys and CommonSpirit to expand access, reduce burdens, and set standards for tech-enabled at-home high-acuity services.[4][5]
Contessa's integration into Amedisys positions it for accelerated national scaling, with CMS pilots and health system expansions signaling momentum in dementia, palliative, and recovery care.[5] Trends like AI-driven analytics, broader Medicare home care reimbursements, and chronic disease management will shape its path, potentially evolving it into a dominant platform for comprehensive at-home ecosystems. As healthcare consumerism and cost pressures intensify, Contessa's pioneering model—blending tech, protocols, and partnerships—will likely amplify its role in transforming delivery from facilities to doorsteps, sustaining the upfront savings and outcome gains that defined its rise.[1][3][5]
Contessa has raised $59.5M across 4 funding rounds. Most recently, it raised $33.0M Series D in November 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2019 | $33.0M Series D | Health Velocity Capital | |
| Apr 1, 2018 | $16.0M Series C | Health Velocity Capital | |
| Oct 13, 2016 | $7.0M Other Equity | BlueCross BlueShield Venture Partners, Marshfield Clinic Health System, Martin Ventures, Nashville Capital Network, Sandbox Industries | |
| Dec 2, 2015 | $3.5M Series A | Anna Haghgooie, Charles N. Martin, Sandbox Industries |